I think, despite the lack of an announcement of a major deal, the BIEL team is fulfilling orders placed by many individual users, every day. It may represent peanuts in terms of revenue, but those loyal customers should be recognized for keeping the lights on to the extent they are. Every order counts!
Question now is will the current CEO clean up the outrageous share structure and become the heroic darling of the corporate pharma/pain space before deals are announced, so the stock can fly to the sustainable levels it deserves? The sustained success of BIEL for all shareholders will best be achieved by getting all the ducks in a row at the right time and share structure is the key one.
The Whelans need to 'disappear' 28 billion of their 35 billion shares or so, reduce their holdings to 7 billion, protect the Corp from hostility by aligning with 'friends' and make a ton of money when deals are announced. 35 billion shares at $.0009 is the same as 7 billion at $.0045, so, if 'disappearing' a lot of the stock IBEX received as a result of churning the revolver financing model allows the stock to climb to a sustainable spot in pennyland, versus not, then just get it done! Remaining in the toilet bowl versus sustainable pennyland!
No question, in my mind, that BIEL could be a guiding light out of the cauldron of CV despair if the share structure is fixed and a turnaround announced at the same time as one or more deals with majors. Announce the steps taken. Announce an expanded BoD. Such announcements and a broader distribution of news of ActiPatch, FDA cleared, USPTO patented, drug-free, side-effect free miniaturized pain remediation device? Bye bye toilets! Stock soars!!!
Even with the communication to shareholders, by the current CEO, who should be working on fixing the outrageous share structure from home, my senses are still twitching big time that something is up - it's just too quiet and VP Sales, Keith Nalepka has been silent . . . soon?
